| International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma AW Lee, WT Ng, JJ Pan, CL Chiang, SS Poh, HC Choi, YC Ahn, ... International Journal of Radiation Oncology* Biology* Physics 105 (3), 567-580, 2019 | 148 | 2019 |
| Combined stereotactic body radiotherapy and checkpoint inhibition in unresectable hepatocellular carcinoma: a potential synergistic treatment strategy CL Chiang, ACY Chan, KWH Chiu, FM Kong Frontiers in Oncology 9, 1157, 2019 | 103 | 2019 |
| Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable … CL Chiang, KWH Chiu, KSK Chan, FAS Lee, JCB Li, CWS Wan, WC Dai, ... The Lancet Gastroenterology & Hepatology 8 (2), 169-178, 2023 | 79 | 2023 |
| Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure TC Lam, KC Tsang, HC Choi, VH Lee, KO Lam, CL Chiang, TH So, ... Lung Cancer 159, 18-26, 2021 | 66 | 2021 |
| Efficacy and safety of radiotherapy for primary liver cancer W Chen, CL Chiang, LA Dawson Chinese Clinical Oncology, 2020 | 63 | 2020 |
| Lymphopenia and radiation dose to circulating lymphocytes with neoadjuvant chemoradiation in esophageal squamous cell carcinoma TH So, SK Chan, WL Chan, H Choi, CL Chiang, V Lee, TC Lam, I Wong, ... Advances in Radiation Oncology 5 (5), 880-888, 2020 | 49 | 2020 |
| Randomized phase II study of the X-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) FAS Lee, BCY Zee, FY Cheung, P Kwong, CL Chiang, KC Leung, ... American Journal of Clinical Oncology 39 (6), 609-613, 2016 | 48 | 2016 |
| First-line atezolizumab plus bevacizumab versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis CL Chiang, SK Chan, SF Lee, HCW Choi Cancers 13 (5), 931, 2021 | 42 | 2021 |
| Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy … CHM Ho, CL Chiang, FAS Lee, HCW Choi, JCH Chan, CSY Yeung, ... Oncotarget 9 (48), 28818, 2018 | 42 | 2018 |
| Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: A systematic review of the literature CL Chiang, Q Guo, WT Ng, S Lin, TSW Ma, Z Xu, Y Xiao, J Li, T Lu, ... Frontiers in oncology 11, 703995, 2021 | 41 | 2021 |
| Cost-effectiveness of pembrolizumab as a second-line therapy for hepatocellular carcinoma C Chiang, S Chan, S Lee, IO Wong, HC Choi JAMA Network Open 4 (1), e2033761-e2033761, 2021 | 41 | 2021 |
| Management of nasopharyngeal carcinoma: is adjuvant therapy needed? VH Lee, KO Lam, AT Chang, TC Lam, CL Chiang, TH So, CW Choi, ... Journal of oncology practice 14 (10), 594-602, 2018 | 40 | 2018 |
| Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis TCL Wong, CL Chiang, AS Lee, VHF Lee, CSY Yeung, CHM Ho, ... Surgical Oncology 28, 228-235, 2019 | 39 | 2019 |
| Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG WT Ng, ECY Wong, AKW Cheung, JCH Chow, DMC Poon, JWY Lai, ... Head & neck 41 (10), 3661-3669, 2019 | 37 | 2019 |
| Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas MKH Chan, V Lee, CL Chiang, FAS Lee, G Law, NY Sin, KL Siu, ... Strahlentherapie und Onkologie 192 (2), 92, 2016 | 34 | 2016 |
| Palliative liver radiotherapy (RT) for symptomatic hepatocellular carcinoma (HCC) CSY Yeung, CL Chiang, NSM Wong, SK Ha, KS Tsang, CHM Ho, B Wang, ... Scientific Reports 10 (1), 1254, 2020 | 30 | 2020 |
| Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B–C hepatocellular carcinoma CL Chiang, MKH Chan, CSY Yeung, CHM Ho, FAS Lee, VWY Lee, ... Strahlentherapie und Onkologie 195 (3), 254-264, 2019 | 24 | 2019 |
| Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: a territory-wide study by HKNPCSG JCH Chow, AHP Tam, KM Cheung, VHF Lee, CL Chiang, M Tong, ... Oral Oncology 111, 105012, 2020 | 23 | 2020 |
| Combined stereotactic body radiotherapy and immunotherapy versus transarterial chemoembolization in locally advanced hepatocellular carcinoma: a propensity score matching analysis CL Chiang, KWH Chiu, FAS Lee, FMS Kong, ACY Chan Frontiers in Oncology 11, 798832, 2021 | 22 | 2021 |
| Cost-effectiveness analysis of Abiraterone Acetate versus Docetaxel in the management of metastatic castration-sensitive prostate cancer: Hong Kong’s perspective CL Chiang, TH So, TC Lam, HCW Choi Prostate Cancer and Prostatic Diseases 23 (1), 108-115, 2020 | 20 | 2020 |
